Biokey Overview
- Year Founded
-
2000
- Status
-
IPO Registration
- Employees
-
11
- Latest Deal Type
-
IPO
- (Announced)
Biokey General Information
Description
Biokey Cayman Inc is a nutraceutical and functional ingredient company focused on the research, development, and commercialization of clinically supported botanical extracts and dietary supplement formulations. The Company also operates as the core Contract Research, Development, and Manufacturing Organization (CRO/CDMO) within the group, providing formulation support, pilot-scale production, analytical testing, and manufacturing coordination for plant-based wellness products.
Contact Information
Website
www.biokeyinc.comCorporate Office
- 44370 Old Warm Springs Boulevard
- Fremont, CA 94538
- United States
Corporate Office
- 44370 Old Warm Springs Boulevard
- Fremont, CA 94538
- United States
Biokey Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. IPO | 23-Jun-2026 | Announced | Generating Revenue | |||
| 5. Merger/Acquisition | 08-Feb-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 09-Apr-2010 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 27-Oct-2006 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 13-Dec-2004 | $1.16M | $4.66M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 29-Jan-2001 | $3.5M | $3.5M | Completed | Startup |
Biokey Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series C Nonvoting | ||||||||
| Series B | 1,160,000 | $0.06 | $1 | $1 | 1x | $1 | 3.87% | |
| Series A | 7,000,000 | $0.03 | $0.5 | $0.5 | 1x | $0.5 | 23.33% |
Biokey Patents
Biokey Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2012116066-A1 | Controlled release hydrogel formulation | Inactive | 22-Feb-2011 | ||
| US-20100239681-A1 | Controlled release particulates containing water-insoluble drug | Inactive | 20-Mar-2009 | ||
| WO-2010108077-A2 | Controlled release particulates containing water-insoluble drug | Inactive | 20-Mar-2009 | ||
| WO-2010108077-A3 | Controlled release particulates containing water-insoluble drug | Inactive | 20-Mar-2009 | ||
| US-20080146534-A1 | Antilipemic agent combined with phosphodiesterase iii inhibing vasodilator and/or platelet aggregation inhibitor; atherosclerosis and related diseases | Inactive | 14-Dec-2006 | A61K45/06 |
Biokey Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biokey FAQs
-
When was Biokey founded?
Biokey was founded in 2000.
-
Where is Biokey headquartered?
Biokey is headquartered in Fremont, CA.
-
What is the size of Biokey?
Biokey has 11 total employees.
-
What industry is Biokey in?
Biokey’s primary industry is Biotechnology.
-
Is Biokey a private or public company?
Biokey is a Private company.
-
What is Biokey’s current revenue?
The current revenue for Biokey is .
-
How much funding has Biokey raised over time?
Biokey has raised $19.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
